Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
The Journal of Urology
|
February 24, 2009
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study
David R Staskin, Roger R Dmochowski, Peter K Sand, et al.
Mayo Clinic Proceedings
|
September 9, 2008
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study
Scott A MacDiarmid, Kenneth M Peters, Andrew Chen, et al.
BJU International
|
February 27, 2003
The role of neuromodulation in the management of urinary urge incontinence
P Abrams, J G Blaivas, C J Fowler, et al.
Urology
|
June 15, 2019
A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome
Kathleen Kobashi, Victor Nitti, Eric Margolis, et al.
Non-Coding RNA Research
|
August 31, 2018
Translational applications of microRNAs in cancer, and therapeutic implications
Grace T Kwok, Jing Ting Zhao, Jocelyn Weiss, et al.
The Journal of Urology
|
February 23, 2010
Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial
Kenneth M Peters, Donna J Carrico, Ramon A Perez-Marrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2023
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells
Vinod Ganju, Gavin Marx, Scott Pattison, et al.
The American Journal of Medicine
|
February 18, 2006
Management of incontinence for family practice physicians
John P Lavelle, Mickey Karram, Franklin M Chu, et al.
Neurourology and Urodynamics
|
June 8, 2012
Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study
Kenneth M Peters, Donna J Carrico, Scott A MacDiarmid, et al.
Frontiers in Immunology
|
February 23, 2023
Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Steven Y Gao, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
The Journal of Urology
|
February 24, 2009
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study
David R Staskin, Roger R Dmochowski, Peter K Sand, et al.
Mayo Clinic Proceedings
|
September 9, 2008
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study
Scott A MacDiarmid, Kenneth M Peters, Andrew Chen, et al.
BJU International
|
February 27, 2003
The role of neuromodulation in the management of urinary urge incontinence
P Abrams, J G Blaivas, C J Fowler, et al.
Urology
|
June 15, 2019
A Prospective Study to Evaluate Efficacy Using the Nuro Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients With Overactive Bladder Syndrome
Kathleen Kobashi, Victor Nitti, Eric Margolis, et al.
Non-Coding RNA Research
|
August 31, 2018
Translational applications of microRNAs in cancer, and therapeutic implications
Grace T Kwok, Jing Ting Zhao, Jocelyn Weiss, et al.
The Journal of Urology
|
February 23, 2010
Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial
Kenneth M Peters, Donna J Carrico, Ramon A Perez-Marrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2023
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells
Vinod Ganju, Gavin Marx, Scott Pattison, et al.
The American Journal of Medicine
|
February 18, 2006
Management of incontinence for family practice physicians
John P Lavelle, Mickey Karram, Franklin M Chu, et al.
Neurourology and Urodynamics
|
June 8, 2012
Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study
Kenneth M Peters, Donna J Carrico, Scott A MacDiarmid, et al.
Frontiers in Immunology
|
February 23, 2023
Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
Steven Y Gao, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, et al.
Page
of 8